AARD News

Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 - Contact Levi & Korsinsky

Class Action Filed Against Aardvark Therapeutics, Inc. (AARD) Over Securities Violations - Contact Levi & Korsinsky Today

Lost Money on Aardvark Therapeutics, Inc. (AARD)? Urged to Join Class Action Before October 13, 2026 - Contact Levi & Korsinsky

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Pomerantz LLP Announces Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD

AARD Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Aardvark Therapeutics, Inc. Class Action Lawsuit

Securities Fraud Investigation Into Aardvark Therapeutics, Inc. (AARD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

AARD Shareholder Alert: October 13, 2026 Lead Plaintiff Deadline in Aardvark Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky

AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Announces The Filing of a Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD